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Diabetes mellitus (DM) causes an increased production of free radicals that can impair bone healing. Melatonin is a hormone secreted mainly by the pineal gland, which 
participates in the neutralization process of free radicals. Objective: The aim of this 
study was to investigate histologic and biochemical effects of supplemental melatonin 
administration on bone healing and antioxidant defense mechanism in diabetic rats. Material 
and Methods: Eighty-six Sprague-Dawley male rats were used in this study. Diabetes 
mellitus was induced by intraperitoneal (i.p.) administration of 65 mg/kg streptozotocin 
(STZ). Surgical bone defects were prepared in the tibia of each animal. Diabetic animals and 
WKRVHLQFRQWUROJURXSVZHUHWUHDWHGHLWKHUZLWKGDLO\PHODWRQLQǋJDQLPDOGD\LS
diluted in ethanol, only ethanol, or sterile saline solution. Rats were humanely killed at the 
10th and 30th postoperative days. Plasma levels of Advanced Oxidation Protein Products 
(AOPP), Malondialdehyde (MDA), and Superoxide Dismutase (SOD) were measured. The 
number of osteoblasts, blood vessels and the area of new mineralized tissue formation were 
calculated in histologic sections. Results: At the 10th day, DM+MEL (rats receiving both STZ 
DQGPHODWRQLQJURXSKDGVLJQL¿FDQWO\KLJKHUQXPEHURIRVWHREODVWVDQGEORRGYHVVHOVDV
well as larger new mineralized tissue surfaces (p<0.05 for each) when compared with DM 
group. At the 30thGD\'0JURXSWUHDWHGZLWKPHODWRQLQKDGVLJQL¿FDQWO\ORZHUOHYHOVRI
AOPP and MDA than those of DM group (p<0.05). Conclusion: Melatonin administration in 
67=LQGXFHGGLDEHWLFUDWVUHGXFHGR[LGDWLYHVWUHVVUHODWHGELRPDUNHUVDQGVKRZHGEHQH¿FLDO
effects on bone healing at short term.
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INTRODUCTION
Diabetes mellitus (DM) is a group of metabolic 
diseases characterized by hyperglycemia resulting 
from defects in insulin secretion, insulin action, or 
both5. It is caused by either autoimmune destruction 
of insulin-producing cells (Type I) or resistance of 
the body to insulin (Type II). Diabetes mellitus 
causes long term chronic complications, such 
as increased fracture risk, poor osseous healing 
characteristics and impaired bone regeneration 
potential, by modulating oxidative stress in various 
systems25.
Oxidative stress generates mainly from glucose 
autoxidation, which leads to free radical and 
reactive oxygen species (ROS) formations. These 
formations are routinely produced as products of 
normal cellular metabolism in aerobic organisms. 
6LQFH IUHH UDGLFDOV KDYH EHQH¿FLDO DQG KDUPIXO
effects, it is of utmost importance to maintain the 
balance between the reactive species and radical 
scavenging mechanisms known as antioxidants. 
Oxidative stress derives from overproduction 
of ROS and the inadequacy of enzymatic and 
non-enzymatic antioxidant defense mechanisms 
that lead to an imbalance in the equilibration of 
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cellular oxidation/reduction. Diabetes mellitus 
leads to hyperglycemia, enhanced and prolonged 
LQÀDPPDWLRQDVZHOODVJHQHUDWLRQRI526ZKLFK
in turn may adversely affect bone healing through 
HQKDQFHGH[SUHVVLRQRISURLQÀDPPDWRU\F\WRNLQHV
that reduce osteoblast differentiation, osteoblast 
activity and increase osteoblast apoptosis. Reactive 
oxygen species induce a broad range of responses 
including proliferation, growth, differentiation 
and cell death by activating numerous signaling 
pathways14. Excessive production of ROS induced 
by hyperglycemia causes deleterious effects on 
lipids and proteins by altering their structures 
and functions25. These molecules participate in 
the conversion of non-radical lipid molecules 
to radicals, which leads to a chain reaction 
called lipid peroxidation. Lipid peroxidation 
SURGXFWVFRXOGLPSDLUWKHÀH[LELOLW\SHUPHDELOLW\
LQWHJULW\ DQG ÀXLGLW\ RI WKH FHOO PHPEUDQH $
well-established marker of lipid peroxidation, the 
Malondialdehyde (MDA), is a low molecular weight 
end-product of this process that can be measured 
by spectrophotometry6. Advanced oxidation protein 
products (AOPPs) are dityrosine-containing, cross-
linking protein products described as novel markers 
of oxidant-mediated protein damage. Advanced 
oxidation protein product is formed by the action of 
chlorinated oxidants produced by myeloperoxidase 
in activated neutrophils. This product is considered 
a reliable marker to evaluate the degree of protein 
oxidation, and is accumulated in biological systems. 
Increased plasma levels of AOPP may be observed 
in long-term diabetic complications that cause 
structural and functional damage in biological 
membranes and endothelium23. To counter harmful 
effects of excess free radicals, organisms develop 
antioxidant defense mechanisms that consist of 
enzymatic and non-enzymatic reactions. Superoxide 
dismutase (SOD) enzyme activity enhances the 
spontaneous dismutation of superoxide anion to 
hydrogen peroxide and oxygen molecules, which 
decompose to oxygen and water. During oxidative 
burst, the activity and level of SOD increase in 
tissues. Current research is focused on reducing 
diabetes induced ROS damage using various free 
radical-scavenging enzymatic or non-enzymatic 
antioxidants8.
The radical scavenger antioxidant melatonin 
(N-acetyl-5-methoxytryptamine) is a hormone 
secreted mainly by the pineal gland, which has 
the ability to stimulate antioxidant enzymes that 
neutralize free radicals and ROS. Melatonin also 
contributes to the maintenance of bone health by 
promoting osteoblast differentiation and limiting 
osteoclastic activity. Bone healing process consists of 
LQÀDPPDWRU\SUROLIHUDWLYHDQGUHPRGHOLQJSKDVHV
The production of free radicals causes cell damage 
and disruption of bone healing process due to the 
chain reactions of protein and lipid peroxidation. 
Melatonin participates in the physiological functions 
of bone cells, promotes angiogenesis and, through 
its free radical scavenging properties, it may also 
serve as a preventive agent against radical-induced 
hard tissue damages12.
Impaired wound healing in Type I DM warranted 
further research on supplemental substances that 
PD\SURYLGHEHQH¿FLDOHIIHFWVLQWKHSUHVHUYDWLRQ
of bone structures. As far as we know, there is a 
limited number of studies that focus on the potential 
effects of melatonin on the healing of hard tissue 
wounds and biochemical markers of free-radical 
mediated damage in Type I DM. Therefore, the 
aim of the this study was to investigate the effects 
of supplemental melatonin administration on 
the histologic variables of bone healing process, 
oxidative stress and biomarkers of antioxidant 
defense mechanism in STZ-induced diabetic rats.
MATERIAL AND METHODS
Experimental animals and study groups
All procedures were reviewed and approved by 
the Institutional Animal Care and Use Committee of 
the Istanbul University, Institute for Experimental 
Medical Research (Project No. 2012/153). 
Experiments were carried out on 10-12 week-old 
adult male Sprague-Dawley rats (N=86) weighing 
approximately 300±20 g, obtained from the Institute 
for Experimental Medical Research. All animals were 
housed in metallic cages in a temperature (22±1°C) 
and humidity (40-60%) of a controlled room with 
a 12 hours dark/light cycle (lights on at 08:00). 
Rats were given ad libitum access to commercial 
standard chow and tap water. The body weights 
were daily recorded throughout the experiments. 
After one week of acclimatization, animals were 
randomly allocated to six main groups concerning 
the substances that will be administered alone or 
LQFRPELQDWLRQ6LQFHWZRVDFUL¿FDWLRQWLPHSRLQWV
(10th and 30th postoperative days) were determined 
before the experiments, the main groups were 
further divided into two subgroups. Therefore, 
there were 12 experimental groups involved in this 
study. Those which had only STZ injection were 
described as DM group (n=15), whereas rats which 
UHFHLYHGERWK67=DQGPHODWRQLQZHUH LGHQWL¿HG
as DM+MEL group (n=15). Animals injected with 
both STZ and ethanol were grouped under DM+ETN 
entity (n=14). Non-diabetic animals, which will be 
injected with same doses of either melatonin (MEL 
group, n=14), ethanol (ETN group, n=14), or sterile 
VDOLQHVROXWLRQ&217JURXSQ ZHUHLGHQWL¿HG
as diabetic animals. See Table 1 and 2 for number 
of animals in each subgroup.
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STZ preparation and administration
A dose of STZ was individually calculated for 
each animal. STZ powder (Streptozotocin U-9889, 
Santa Cruz Biotechnology Inc, Dallas, TX, USA) was 
transferred into microfuge tubes and maintained at 
-20°C. The streptozotocin was kept in unbroken cold 
chain and freshly dissolved in citrate buffer before 
administration. Animals were fasted overnight for 12 
hours with free water access before STZ injections. 
Type I DM was induced by single intraperitoneal 
injection of 65 mg/kg STZ dissolved in citrate buffer 
(0.1 M; pH 4.5) in a volume of 0.5 mL.
Fasting blood glucose measurement and 
urine analysis
Three days after diabetes induction, blood 
samples obtained from tail veins were analyzed 
for fasting blood glucose using a glucometer 
(Major II Blood Glucose Monitoring System, Major 
Biosystems Corp, New Taipei City, Taiwan). Animals 
were considered Type I DM if blood glucose level 
exceeds 200 mg/dl1,30. During the experiments, 
urine glucose measurements were weekly evaluated 
by using urine test strips (Urine Reagent Strip-10 
URS-10, Teco Diagnostics, Anaheim, CA, USA).
Surgical procedures
Four weeks after the induction of DM, rats 
were anesthetized using i.p. injection of 5 mg/kg 
of Xylazin hydrochloride (Rompun®, Bayer Turk 
Kimya San. Ltd. Sti. Istanbul, Turkey) and 60 
mg/kg of Ketamin HCl (Ketanest®, Parke Davis, 
Berlin, Germany). Medial surfaces of right tibiae 
were shaved and disinfected. A two centimeter 
longitudinal incision was performed along the frontal 
aspect and bone was exposed by blunt dissection. 
A single, non-critical corticocancellous bone defect 
of 2.1 mm, both in diameter and in depth, was 
prepared in the right tibiae of each animal under 
copious amount of sterile saline irrigation using a 
dental bur (HM 71 021, Meisinger, Hager&Meisinger 
GmbH, Neuss, Germany) attached to a surgical 
physio dispenser (X Cube V2.0, Saeshin Precision 
Co, Daegu, Korea) (Figure. 1). The surgical wounds 
were closed with 3.0 surgical silk sutures (Dogsan 
7LEEL 0DO]HPH 6DQ $6 øVWDQEXO 7XUNH\ $OO
injections started immediately after the surgery.
Melatonin and ethanol administration
Melatonin (Santa Cruz Biotechnology, Dallas, 
7;86$ZDV¿UVW GLVVROYHG LQ DEVROXWH HWKDQRO
(Tekkim Kimya San. Ltd. Sti. Bursa, Turkey), in 
physiological saline solution and then maintained 
at -20°C. Rats were daily injected with melatonin 
(250 μg/animal/day/i.p.) diluted in 1% ethanol-
physiological saline solution, in a volume of 0.5 
mL, between 19:00 and 20:00 h. The same dose of 
ethanol without additional melatonin was injected 
to animals in ETN group.
Histological preparation and analysis 
The rats were humanely euthanized and tibiae 
were excised. Samples were fixated in 10% 
buffered formaldehyde solution. About 8 to 12 
KRXUVDIWHU¿[DWLRQVRIWWLVVXHVZHUHFOHDQHGDQG
VSHFLPHQVZHUHGHFDOFL¿HGLQIRUPLFDFLGVRGLXP
nitrate solution. The regions with bone defects were 
VHFWLRQHGDQGHPEHGGHG LQSDUDI¿Q0LGVDJLWWDO
VHULDOVHFWLRQVRIǋPWKLFNZHUHSUHSDUHGDQG
stained with hematoxylin and eosin (H&E) and 
Masson’s trichrome stains. The histologic sections 
were examined using light microscopy at x100 
DQG[PDJQL¿FDWLRQV1XPEHUVRIRVWHREODVWV
and blood vessels were counted in sections. New 
mineralized tissue formation and blood vessel 
area were measured using Olympus Soft Imaging 
System AnalySIS FIVE® digital imaging software 
(Olympus Optical Co. LTD, Tokyo, Japan). Five 
¿HOGVZHUHUDQGRPO\VHOHFWHGLQHDFKVHFWLRQDQG
the calculated area was expressed as mean % ± 
6'RIWKHFRUUHVSRQGLQJ¿HOGRIYLHZ
Biochemical analyses
Following 12 hours of fasting, intracardiac 
blood samples were collected into EDTA vacutainer 
tubes. Samples were centrifuged at 3000 g 
for 10 min at 4°C and plasma was stored in 
aliquots at -80°C. The AOPP was measured by 
spectrophotometry on a microplate reader (UV-
1601 Visible Spectrophotometer, Shimadzu Corp., 
Kyoto, Japan). The absorbance was read at 340 
nm. Concentrations of AOPP were expressed as 
ǋPRO/ FKORUDPLQH7 HTXLYDOHQWV ZKLFK ZHUH
DEEUHYLDWHG WR ǋPRO/ For MDA assay, the 
supernatant absorbance was measured at 535 nm. 
MDA values were expressed as nmol/mL using a 
PRODUH[WLQFWLRQFRHI¿FLHQWRI[0-1 cm-1 
2. Superoxide dismutase activity was evaluated by 
using BMassay Rat Super Oxide Dismutase ELISA 
Kit (Bio-Medical Assay Co., Ltd, Beijing, China). The 
absorbance was measured with an ELISA reader 
at 450 nm (Rayto Spectrophotometer RT-1904C, 
Rayto Life and Analytical Sci, Co, Ltd, Shenzhen, 
China) and a standard curve was used.
Statistical analysis
Statistical Package for Social Sciences (SPSS) 
for Windows, Version 15.0 (SPSS Inc, Chicago, 
USA) software was used in this study. Since all of 
the variables consisted of numerical values, data 
ZHUH ¿UVW HYDOXDWHG ZLWK descriptive statistical 
methods such as mean, median, variance and 
standard deviation. Kolmogorov–Smirnov test was 
used to check whether distribution of the sample 
is consistent with normality assumptions. Levene’s 
test was employed to assess the homogeneity 
YILDIRIMTURK S, BATU S, ALATLI C, OLGAC V, FIRAT D, SIRIN Y
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of variances. For variables that meet the criteria 
for normal distribution, the Analysis of Variance 
(ANOVA) test was used for multiple comparisons. 
Post-hoc tests; Tukey’s Honestly Significant 
Difference (HSD) Test or Tamhane T2 were 
performed for pairwise comparisons for equal and 
unequal variances, respectively. Kruskal-Wallis and 
Mann-Whitney U test with Bonferroni correction 
were applied for variables that did not meet the 
criteria for normal distribution. The comparisons 
between two independent groups were performed 
using the Independent-Samples T test or Mann-
Whitney U test depending on the distribution of the 
data. For the assessment of dependent variables 
that were normally distributed, Paired-Samples T 
test was used, which was substituted by Wilcoxon 
Signed Rank Test when dependent variables are not 
normally distributed. The results were evaluated 
LQDFRQ¿GHQFH LQWHUYDORIDQGp<0.05 was 
FRQVLGHUHGVWDWLVWLFDOO\VLJQL¿FDQW7KHp value was 
adjusted to p1<0.003 when Mann-Whitney U test 
with Bonferroni correction was applied.
RESULTS
Body weight and fasting blood glucose 
measurements 
Mean body weights of all diabetic rats 
(239.74±23.53 g and 254.76±28.16 g at 10th and 
30th GD\V UHVSHFWLYHO\ VLJQL¿FDQWO\ GHFUHDVHG
when compared with their initial mean body weights 
(295.3±11.9 g and 292.07±11.28 g at 10th and 30th 
days, respectively) (p<0.05). On the other hand, a 
VLJQL¿FDQWZHLJKWJDLQSDWWHUQZDVGHWHFWHGLQQRQ
diabetic groups (300.38±11.04 g, 329.07±11.36 g, 
at 10th and 30th days, respectively) compared with 
their initial mean body weights (291.42±8.37 g and 
287.35±3.38 g at 10th and 30th days, respectively) 
(p<0.05). The mean value of fasting blood glucose 
level in diabetic groups (366.91±63.56 mg/dl) 
ZDVVLJQL¿FDQWO\KLJKHU WKDQ WKHEDVHOLQHYDOXHV
(85.65±8.18 mg/dl) (p<0.05).
Biochemical evaluation
$VLJQL¿FDQWGLIIHUHQFHZDVIRXQGEHWZHHQWKH
study groups at the 10th day in AOPP levels. The 
PHDQRI'0JURXSZDV VLJQL¿FDQWO\ KLJKHU WKDQ
those of ETN, MEL, and CONT groups (p<0.05). 
At the 30th day, the mean of DM group was found 
WREHVLJQL¿FDQWO\KLJKHUWKDQWKH'00(/(71
MEL, and CONT groups (p<0.05). Furthermore, 
the mean of DM+ETN group was higher than that 
of DM+MEL group (p<0.05) (Table 1). At the 10th 
GD\0'$OHYHOVZHUHREVHUYHGWREHVLJQL¿FDQWO\
higher in DM group than those of ETN, MEL, and 
CONT groups (p<0.05). At the same time, DM+ETN 
JURXSGHPRQVWUDWHGVLJQL¿FDQWO\KLJKHU OHYHOVRI
MDA than ETN, MEL, and CONT groups (p<0.05). 
At the 30thGD\VLJQL¿FDQWO\KLJKHU OHYHORI0'$
was detected in DM group when compared with 
DM+MEL, ETN, MEL, and CONT groups (p<0.05) 
(Table 1). The median of SOD in DM group was 
VLJQL¿FDQWO\KLJKHUWKDQWKDWRI'0(71JURXSDW
the 10th day (p1<0.003). At 30th day, the mean SOD 
levels in DM, DM+MEL, and DM+ETN groups were 
lower than those of ETN, MEL, and CONT groups 
(p<0.05) (Table 1).
Day n Groups $233ȝPRO/ 0'$ȝPRO/ SOD (U/ml)
10 8 DM 88.26±17.87A,B,C 2.41±0.24A,B,C 54.59±16.6 (48.3)A
10 8 DM+MEL 52.47±25.93 1.99±0.56 48.13±5.14 (46.7) 
10 7 DM+ETN 93.52±36.71 2.3±0.28D,E,F 38.88±1.99 (38.7)A
10 7 ETN 50.56±15.02A 1.2±0.38A,D 41.33±8.62 (31.7)
10 7 MEL 49.56±15.02B 1.62±0.26B,E 43.68±7.38 (45.1)
10 7 CONT 41.73±20.64C 1.59±0.39C,F 46.18±21.6 (35)
30 7 DM 104.42±17.7A,B,C,D 2.55±0.08A,B,C,D 35.87±6.35(36.7)A,B
30 7 DM+MEL 29.42±20.83A,E 1.58±0.37A,E 37.57±4.27 (37.7)C,D
30 7 DM+ETN 98.16±34.96E 2.29±0.25E,F,G 35.75±3.36 (35.3)E,F
30 7 ETN 42.45±21.57B 1.45±0.18B,H 42.15±7.03(36)G,H
30 7 MEL 40.09±10.85C 1.23±0.37C,F,H 46.07±4.02 (45)A,C,E,G
30 7 CONT 42.09±10.84D 1.43±0.37D,G 45.4±2.32 (46.2)B,D,F,H
Table 1- Measurement of biochemical variables in study groups. Data were expressed as mean±standard deviation except 
for SOD group, in which the median values have been presented between parentheses. (AOPP: Advanced Oxidation 
Protein Products; MDA: Malondialdehyde; SOD: Superoxide Dismutase; DM: Diabetes Mellitus; MEL: Melatonin; ETN: 
Ethanol; CONT: Control)
8SSHUFDVHOHWWHUVLQWKHVDPHFROXPQLQGLFDWHVLJQL¿FDQWGLIIHUHQFHEHWZHHQWZRJURXSVDWWKHVDPHWLPHSRLQWV
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Light microscopy observations
Osteoblast count
At the 10th GD\ D VLJQL¿FDQW GHFUHDVH LQ WKH
mean number of osteoblasts was detected in DM 
group when compared with those of DM+MEL, 
ETN, MEL, and CONT groups (p<0.05). The mean 
osteoblast count in DM+MEL group was found to 
EHVLJQL¿FDQWO\KLJKHUWKDQWKDWRI'0(71JURXS
ZKHUHDVLWZDVVLJQL¿FDQWO\ORZHUWKDQWKHPHDQ
number of osteoblasts in ETN, MEL, and CONT 
groups (p<0.05). In non-diabetic groups, young 
osteoblasts, cuboidal and robust, were observed 
in a regular arrangement at the 10th day (Figure 
7). However, in diabetic groups, uneven shaped 
osteoblasts were irregularly lined up and were found 
Day n Groups Osteoblast Count New Mineralized 
Tissue Area (mm2)
Blood Vessel 
Count
Blood Vessel Area 
(mm2)
10 8 DM 157.5±22.26A,B,C,D 0.16±0.08A,B,C,D 18±5.98A,B,C,D 0.0043±0.0007A,B,C,D
10 8 DM+MEL 227.5±33.9A,E,F,G,H 0.39±0.11A,E,F 30.75±6.36A,E,F,G,H 0.0125±0.001A,E,F,G
10 7 DM+ETN 165.42±24.77E,I,K,L 0.26±0.05G,H 18.28±7.58E,I,J,K 0.0034±0.0008E,H,I,K
10 7 ETN 291.57±6.45B,F,I 0.53±0.14B,I,K 42.71±7.3B,F,I 0.0171±0.001B,H,L,M
10 7 MEL 289.43±8.18C,G,K 0.64±0.12C,E,G,I 46.28±6.23C,G,J 0.0174±0.0018C,F,I,L
10 7 CONT 289.42±10.64D,H,L 0.63±0.14D,F,H,K 46.57±6.7D,H,K 0.0176±0.0022D,G,K,M
30 7 DM 127.57±14.66 0.45±0.06(0.43)A,B,C 9.42±2.99A,B,C 0.0022±0.0005A,B,C
30 7 DM+MEL 116±25.94 0.52±0.09(0.56)D,E 9.57±4.11D,E,F 0.0031±0.0023D,E,F
30 7 DM+ETN 127.71±22.02 0.47±0.11(0.44)F,G 10.14±1.77G,H,I 0.0024±0.0005G,H,I
30 7 ETN 150.57±10.98 0.79±0.11(0.78)A 24.85±2.11A,D,G,K 0.0095±0.0018A,D,G
30 7 MEL 152.28±21.14 0.82±0.03(0.81)B,D,F 33.14±12.38B,D,E,H 0.014±0.0027B,E,H
30 7 CONT 151.28±46.97 0.81±0.04(0.8)C,E,G 32.28±7.25C,E,F,I,K 0.0142±0.0028C,F,I
8SSHUFDVHOHWWHUVLQWKHVDPHFROXPQLQGLFDWHVLJQL¿FDQWGLIIHUHQFHEHWZHHQWZRJURXSVDWWKHVDPHWLPHSRLQWV
Table 2- Measurement of osteoblast, new mineralized tissue area, and blood vessel in study groups. Data were expressed 
as mean±standard deviation. (DM: Diabetes Mellitus; MEL: Melatonin; ETN: Ethanol; CONT: Control)
Figure 1- Macroscopic view of the bone defect in the right 
tibia
Figure 2- Irregularly arranged osteoblasts (thin white arrow) and large multinucleated osteoclast-like cells (thick yellow 
arrows) observed in the section of DM group at the 10th day (hematoxylin & eosin x400)
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to be disorganized (Figure. 2). It was noted that the 
new mineralized tissue formation had been almost 
completed at the 30th day (Figure 6).
Number and area of blood vessels
In 10th day specimens, the mean number of 
blood vessels and mean area occupied in sections 
ZHUHERWKVLJQL¿FDQWO\ORZHULQ'0JURXSWKDQWKRVH
measured in DM+MEL, ETN, MEL, and CONT groups 
(p<0.05). Although DM+MEL group demonstrated a 
VLJQL¿FDQWLQFUHDVHFRPSDUHGZLWK'0(71JURXS
in both variables (p<0.05), these were still lower 
than those of non-diabetic groups (p<0.05). In 
30-day-old specimens, the mean number and area 
RIEORRGYHVVHOVZHUHVLJQL¿FDQWO\KLJKHULQQRQ
diabetic groups than those calculated in diabetic 
rats (p<0.05, Table 2).
New mineralized tissue formation
In 10th day specimens, the mean area of new 
mineralized tissue formation was significantly 
lower in DM when compared with DM+MEL, ETN, 
MEL, and CONT groups (p<0.05). Furthermore, 
the means of DM+MEL, DM+ETN, and ETN groups 
ZHUH VLJQL¿FDQWO\ ORZHU WKDQ WKRVH RI 0(/ DQG
CONT groups (p<0.05). In 30th day specimens, 
the mean area of new mineralized tissue was 
VLJQL¿FDQWO\ORZHULQ'0JURXSWKDQLQ(710(/
and CONT groups specimens (p1<0.003) (Figure 3). 
In addition, the means of DM+MEL and DM+ETN 
Figure 3- +LVWRORJLFDO YLHZRI WKHGHIHFW WKDW LV QHDUO\ ¿OOHGZLWKQHZPLQHUDOL]HG WLVVXH LQ'0JURXSDW WKHth day 
(hematoxylin & eosin x40)
Figure 4- At the 10thGD\KHPDWRPDIRUPDWLRQZDVDSSDUHQWLQWKHGHIHFWDUHDVXUURXQGHGE\¿EURVLVDQGWKLQWUDEHFXODH
of new mineralized tissue in DM+MEL group (hematoxylin & eosin x100)
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ZHUH VLJQL¿FDQWO\ ORZHU WKDQ WKRVH RI 0(/ DQG
CONT groups (p1<0.003). In 10th day specimens, 
hematoma formation was clearly visible in the 
center of bone defects. In DM+MEL groups, the 
KHPDWRPDZDV VXUURXQGHG E\ ¿EURVLV DUHD DQG
thin trabeculae of new mineralized tissue (Figure 
4 and Figure 5).
DISCUSSION
'LDEHWHVPHOOLWXVSRVHVDVLJQL¿FDQWWKUHDWWR
the quality of life and constitutes a considerable 
health-care burden. On 2014, approximately 387 
million people worldwide were living with DM, 
which will probably reach 592 million by the year of 
203516. Therefore, experimental research on DM is 
DYDOXDEOHDGMXQFWWRVFLHQWL¿FDUVHQDOWRHOXFLGDWH
different aspects of this disease. Various animal 
species have been used for this purpose, but male 
rodents, especially rats, are generally preferred 
because of their hormonal characteristics, high 
reproduction rates, availability at reasonable cost 
and ease of maintenance. Commercial availability, 
the presence of well-established methodology and 
low animal mortality rates have made the STZ the 
agent most commonly employed to induce DM. 
Accordingly, we administered a single dose of 65 
mg/kg i.p. STZ to induce irreversible DM in male 
rats. Cellular proliferation has been reported to 
UHDFK LWV SHDN GXULQJ WKH ¿UVWZHHN SRVWLQMXU\
followed by the maturation of cellular components 
DQGHQGRFKRQGUDORVVL¿FDWLRQZKLFKRFFXUVQHDU
the end of second week. In third week post-injury, 
the osteoblastic activity has been shown to gradually 
Figure 5- Fibrosis and mineralized tissue formation in the defects of DM+MEL groups at the 10th day (Masson’s trichrome 
x100) (Arrow: Blood Vessels)
Figure 6- At the 30thGD\HQGRFKRQGUDOERQHIRUPDWLRQWKLFN\HOORZDUURZVRVWHREODVWVWKLQZKLWHDUURZDQG¿EURVLV
area were detected around the defect in DM+MEL group (hematoxylin & eosin x100)
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decrease and woven bone is replaced by lamellar 
bone13. In experimental Type 1 DM models, waiting 
period of four weeks after the induction of DM is a 
common protocol to establish diabetic condition and 
to let the harmful effects of DM on various organs to 
appear. After eight weeks, these effects have been 
reported to become more pronounced1. Accordingly, 
ZHVHOHFWHGWKHVDFUL¿FHWLPHSRLQWVDVth and 
30th post-operative days to exploit the advantage 
of concurrently using both well-established models 
of bone defect healing and experimental Type 1 
DM. To avoid spontaneous tibia fractures that may 
lead to subsequent infection and create an easily 
reproducible bone defect, we used a commercially 
available 2.1 mm round dental bur. Diabetes 
mellitus has been associated with oxidative stress, 
which leads to impaired wound healing process 
GXH WR GHFUHDVHG LQÀDPPDWRU\ UHVSRQVH ODFN
of well-organized granulation tissue, decreased 
amount of growth factors, poor angiogenesis, 
and altered collagen organization. Structural and 
biochemical damages in cellular components that 
participate in the healing process in DM necessitate 
multi-disciplinary research on substances that may 
overcome the deleterious effects of this disease 
on osseous healing, either by reducing oxidative 
stress or by promoting bone healing process. 
Melatonin hormone may be considered as a viable 
option because of its free-radical scavenging 
SURSHUWLHV0HODWRQLQ FRQWHQW LQ ELRORJLFDO ÀXLGV
gradually increases in the early part of the night, 
reaches its peak level at midnight and decreases 
just before dawn. Claustrat, et al.12 (2005) reported 
that melatonin secretion is related to the duration 
of darkness, reaching a peak at 03:00 to 04:00 h. 
Timing of melatonin administration was selected as 
19:00 hours to be consistent with previous studies 
that have been conducted in rodents26,27. Melatonin 
dose was calculated according to the solubility of 
melatonin powder in ethanol and individual body 
weight of each animal26. In order to determine the 
extent of oxidative stress and to mediate damages 
and the effectiveness of antioxidant defense 
mechanisms that may affect bone healing, we 
analyzed plasma levels of AOPP, MDA, and SOD, 
which are biomarkers previously studied20,30.
Protein and lipid oxidations in clinical or 
experimentally-induced DM may cause inactivation 
of antioxidant defense enzymes, thereby leading 
to structural and functional damages to plasma 
proteins and lipids. In our study, DM induction alone 
FDXVHG VRPH VLJQL¿FDQW DOWHUDWLRQV LQ R[LGDWLYH
stress biomarkers. We have found that plasma 
levels of AOPP were higher in diabetic groups at 
both time points. Consistently, plasma level of 
AOPP has been shown to increase in DM in various 
study designs2,10,23. Çakatay10 (2005) reported 
that subjects with poorly controlled glycaemia had 
higher plasma levels of AOPP than those having 
well-regulated DM. Diabetes mellitus is considered 
to be a major cause of autoxidative glycosylation, 
free radical formation as well as protein and lipid 
oxidation. This process increases intracellular 
IRUPDWLRQ RI JO\FDWHG ELRPROHFXOHV DQG VSHFL¿F
end products such as AOPP. On the other hand, 
MDA levels in DM have been associated with the 
duration of hyperglycemia2,20,30. We detected a 
VLJQL¿FDQW LQFUHDVH LQ0'$ OHYHOV LQ WKH SODVPD
samples obtained from DM groups in our study. 
Membrane lipids are of utmost importance for the 
preservation of cell integrity. Lipid peroxidation may 
lead to enzyme inactivation, cross-link of membrane 
lipids and proteins as well as cell death. In DM, the 
accumulation of Nicotinamide Adenine Dinucleotide 
Phosphate (NADPH), one of the glucose metabolites 
formed as a result of glucose oxidation, enhances 
Figure 7- At the 10th day, osteoblasts (thin white arrow), osteoclast-like cells (thick yellow arrows), and blood vessels 
(triangular white arrowhead) were observed around new mineralized tissue in the defect area of the section obtained from 
CONT group (hematoxylin & eosin x400)
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lipid peroxidation via cytochrome P-450 system. 
Malondialdehyde, which is the end product of lipid 
peroxidation, has been found to increase in DM11. 
The activity of SOD in DM group at the 30th day was 
VLJQL¿FDQWO\ORZHUWKDQ0(/DQG&217JURXSV2XU
result was consistent with previous studies that 
reported that plasma SOD enzyme activity was 
lower in diabetic groups than the controls28. The 
decrease of SOD activity in diabetic groups may 
be attributed to the increase of glycosylated SOD, 
which can lead to the inactivation of this enzyme 
at the end of eight weeks2.
0HODWRQLQ DGPLQLVWUDWLRQ FDXVHG D VLJQL¿FDQW
decrease in AOPP plasma and MDA levels in 
diabetic rats at the 30thGD\7KLV¿QGLQJFRXOGEH
H[SODLQHGE\WKHWLPHGHSHQGHQWLQÀXHQFHSDWWHUQ
of melatonin to exhibit its antioxidant properties 
on lipid metabolism22. Reactive oxygen species 
are by-products of partial O2 reduction during ATP 
synthesis. Hydroxyl radical (HO), which is formed 
during this process, is one of the most aggressive 
radicals that reacts with proteins and lipids. As 
HQ]\PHV\VWHPVFRXOGQRWHI¿FLHQWO\GHWR[LI\+2
antioxidants, which directly scavenge this radical, 
are required to support the antioxidative defense 
system. Melatonin, as a receptor-independent free 
radical scavenger and a broad-spectrum antioxidant, 
was found to be a potent HO scavenger. The 
interaction of melatonin with free radicals generates 
metabolites that contribute to the reduction of lipid 
and protein oxidation. Therefore, melatonin doses 
administered in our study may have led to the 
decrease in the plasma levels of AOPP and MDA. 
2QWKHRWKHUKDQGWKHUHDUHFRQÀLFWLQJDUJXPHQWV
concerning the changes in SOD levels measured in 
the presence of DM and melatonin supplementation. 
No consensus could be reached on this particular 
subject, since some studies indicate higher levels 
of SOD20 whereas others report reduction in the 
enzyme activity3. Considerable inconsistencies that 
exist between the sample types and experimental 
designs used in these studies probably contribute 
WRWKHGLVFUHSDQFLHVUHSRUWHGLQWKHLU¿QGLQJV,Q
our case, the mean plasma level of SOD in DM+MEL 
group was lower than that of the DM group at the 
10th day; however, this difference did not reach 
WKH OHYHORIVWDWLVWLFDOVLJQL¿FDQFH%HVLGHVRWKHU
factors, our limited sample size and strict statistical 
PHWKRGRORJ\PD\KDYHDOVRLQÀXHQFHGWKHVWXG\
outcome.
The histological characteristics and healing 
patterns of hard tissue wounds in DM have been 
investigated using surgical bone defects or fractures 
created in different anatomic regions of small 
animal models. Azad, et al.7 (2009) reported that 
diabetic rats having a segmental femoral defect 
KDGDVLJQL¿FDQWO\ORZHUDUHDRIPLQHUDOL]HGWLVVXH
when compared with non-diabetics at three-week 
period. Hamann, et al.17 (2013), who evaluated the 
bone formation in femoral bone defects of diabetic 
and non-diabetic rats at twelve weeks, have found 
WKDWGLDEHWLFDQLPDOVKDGVLJQL¿FDQWO\ORZHUDPRXQW
of new mineralized tissue when compared to their 
non-diabetic counterparts. In a study conducted by 
Shyng, et al.29DVPDOOQXPEHURIÀDWWHQHG
and inactive osteoblasts were detected overlying 
the immature bone surfaces in the histological 
observations of calvarial defects at three-week 
period. In addition, they demonstrated that necrotic 
bone had persisted at the defect margins, which 
indicates a deformity in the remodeling phase. 
7KHLU¿QGLQJVVXJJHVWWKDWWKHSUHVHQFHRI'0PD\
disrupt mineralization, resorption or remodeling 
phases during bone healing. Follak, et al.15 (2004) 
observed a reduced and retarded mineralization 
SURFHVVLQWKH¿UVWWZRZHHNVRIERQHKHDOLQJLQ
poorly compensated diabetic animals. Similarly, 
Picke, et al.22 (2015) reported lower bone formation 
rate in diabetic rats when compared with controls 
and suggested that DM may have caused histologic 
defects in osteoblasts. Fracture healing may also 
be compromised in DM. Beam, et al.9 (2002), who 
evaluated the effects of DM on the early and late 
phases of fracture healing in diabetic rats, have 
found that cell proliferation in the hard callus of 
diabetic rats decreased to a greater extent than 
that of controls at the 10th day. Also, the cartilage 
area, as well as the size and number of proliferating 
FKRQGURF\WHVZHUHIRXQGWREHVLJQL¿FDQWO\ORZHU
in diabetic rats. The authors reported an obvious 
GHOD\LQWKHHQGRFKRQGUDORVVL¿FDWLRQRIIUDFWXUHVLQ
diabetic rats at eight-week time point. Kayal, et al.19 
(2009) observed smaller cartilage area and more 
prominent osteoclastogenesis in diabetic mice with 
DUWL¿FLDO IHPRUDO IUDFWXUHV WKDQ WKRVHRI FRQWUROV
at the 10th day. The amount of new mineralized 
tissue formation in diabetic mice at 16th and 22th 
GD\VZHUHREVHUYHG WREH VLJQL¿FDQWO\ OHVV WKDQ
those of controls, suggesting that diabetes causes 
a reduction in the endochondral bone formation 
GXULQJ IUDFWXUH UHSDLU 2XU ¿QGLQJV DW WKH th 
day have shown that the new mineralized tissue 
formation, number of osteoblasts and new blood 
vessels, as well as the area occupied in sections, 
ZHUH VLJQL¿FDQWO\ ORZHU LQ '0 JURXSV ZLWKRXW
melatonin supplementation when compared with 
controls. Although it is not possible to directly 
compare these results with those of aforementioned 
studies because of differences in the design 
concepts and the animal species used, we think 
WKDWRXU¿QGLQJVUHSUHVHQWDVLPLODUSDWWHUQZKLFK
indicates deleterious effects of DM on the healing 
of bone defects, particularly in the early phase of 
the process.
Melatonin is thought to affect bone metabolism 
by promoting the proliferation of osteoblasts 
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and the synthesis of osteoprotegerin, which 
leads to the inhibition of the differentiation of 
osteoclast-like cells. When investigated in non-
diabetic animals, Satomura, et al.27 (2007), who 
administered i.p. melatonin to mice, have found 
D VLJQL¿FDQW LQFUHDVH LQ WKH UDWLR RI QHZ WR ROG
bone mass in the surface of femoral cortex. In 
similar experimental settings, Koyama, et al.21 
(2002) reported higher bone mass and trabecular 
thickness, but lower osteoclast surface and number 
in growing young mice treated with melatonin for 
four weeks. Authors concluded that the melatonin 
administered in pharmacologic doses had increased 
bone mass predominantly through suppression 
of bone resorption. Experimental designs that 
include supplemental melatonin administration in 
the presence of bone defects created in diabetic 
subjects are very limited. Yousuf, et al.31 (2013) 
ORFDOO\ DSSOLHGPHODWRQLQ WR DUWL¿FLDO SHULRGRQWDO
defects created in the mandible of STZ induced 
GLDEHWLFUDEELWV7KH\UHSRUWHGVLJQL¿FDQWO\KLJKHU
osteoblast count at three and six weeks, and, at 
the same time points, lower number of osteoclasts 
in melatonin treated DM groups when compared 
with non-treated diabetic rabbits. Authors attributed 
the increase in the amount of new mineralized 
tissue they have found to the aforementioned 
changes in the cell count balance that shifts 
towards osteoblast formation. Kaya, et al.18 (2013) 
evaluated the effects of melatonin administration on 
bone defect healing process in diabetic rats. They 
demonstrated that melatonin-treated diabetic rats 
KDGVLJQL¿FDQWO\LQFUHDVHGYDOXHVRIRVWHRJHQHVLV
LQGLFDWRUVEXWGHFUHDVHGQXPEHURILQÀDPPDWLRQ
markers when compared with those of non-diabetic 
UDWV&RQVLVWHQWZLWKWKHVHVWXGLHVRXU¿QGLQJVDW
the 10th day showed that DM+MEL group had higher 
number of osteoblasts, as well as new mineralized 
tissue formation area, but lower osteoclast-like 
cell count when compared with DM group. The 
evaluation of the number and area of blood vessels 
VKRZHGWKDW'0JURXSKDGVLJQL¿FDQWO\GHFUHDVHG
values compared with those of non-diabetic groups 
at 10th and 30thGD\V7KHVH¿QGLQJVVXSSRUWWKHIDFW
that DM may have impaired new vessel formation. 
Similarly, Altavilla, et al.4 (2001) have shown that 
the level of lipid peroxidation is inversely correlated 
with new vessel formation in diabetic mice. On 
WKHRWKHUKDQG'00(/JURXSKDGVLJQL¿FDQWO\
higher number and area of blood vessels at the 
10th day when compared with DM group, which is in 
accordance with studies29WKDWSUHVHQWVLJQL¿FDQWO\
higher number of blood vessels in melatonin-
administered rats than those of control group in 
HYHU\SKDVHRIZRXQGKHDOLQJ7KHVH¿QGLQJVFRXOG
suggest that melatonin administration is capable 
of ameliorating the deleterious effects of DM on 
blood supply.
CONCLUSION
Within the limits of this experimental study, 
the administration of supplemental melatonin 
in diabetic rats with hard tissue defects has 
demonstrated positive histologic effects on the 
early stage of bone healing and exhibited limited 
free-radical scavenging properties, as evidenced 
by the changes in the plasma levels of oxidative 
stress-related biomarkers.
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